EcoDrugPlus

Diacylglycerol O-Acyltransferase 1a

Ensembl ID : ENSAPEG00000005517
Gene Symbol: DGAT1A
1 Cross references
192 Possible Orthologues:

Diacylglycerol O-Acyltransferase 1b

Ensembl ID : ENSAPEG00000000792
Gene Symbol: DGAT1B
1 Cross references
188 Possible Orthologues:

Dihydroorotate Dehydrogenase

Ensembl ID : ENSAPEG00000018948
Gene Symbol: DHODH
1 Cross references
173 Possible Orthologues:

Dihydropyrimidine Dehydrogenase B

Ensembl ID : ENSAPEG00000010459
Gene Symbol: DPYDB
1 Cross references
217 Possible Orthologues:

Discoidin Domain Receptor Tyrosine Kinase 2

Ensembl ID : ENSAPEG00000009522
Gene Symbol: DDR2
1 Cross references
205 Possible Orthologues:

Dopamine Receptor D1

Ensembl ID : ENSAPEG00000011939
Gene Symbol: DRD1
1 Cross references
189 Possible Orthologues:

Dopamine Receptor D1b

Ensembl ID : ENSAPEG00000017467
Gene Symbol: DRD1B
1 Cross references
201 Possible Orthologues:

Dopamine Receptor D2a

Ensembl ID : ENSAPEG00000012890
Gene Symbol: DRD2A
1 Cross references
206 Possible Orthologues:

Dopamine Receptor D3

Ensembl ID : ENSAPEG00000019252
Gene Symbol: DRD3
1 Cross references
203 Possible Orthologues:

Dopamine Receptor D4a

Ensembl ID : ENSAPEG00000020130
Gene Symbol: DRD4A
1 Cross references
173 Possible Orthologues:

Dopamine Receptor D4b

Ensembl ID : ENSAPEG00000000203
Gene Symbol: DRD4B
1 Cross references
175 Possible Orthologues:

Dopamine Receptor D5

Ensembl ID : ENSAPEG00000001896
Gene Symbol: DRD5
2 Cross references
148 Possible Orthologues:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).